Aspira Women's Health
OTC: AWHLAustin, US · Founded 1993 · Delaware corporation · 58 employees on LinkedIn
Founders & leadership
SM
Sandra MilliganPresident
NS

Nicole SandfordinPresident and CEO, Board Member2022–2024
RB
Robert BeecheyExecutive
VB

Valerie B. PalmieriinExecutive Chairwoman2022–2023
Board
WP
Winfred ParnellBoard director
SC
Stefanie CavanaughBoard director
CF
Celeste FralickBoard director
EO
Ellen O'Connor VosBoard director
JH
Jannie HerchukBoard director
VG
Veronica G. H. JordanBoard director
JT
James T. LaFranceBoard director
JS
James S. BurnsBoard director
Reported raises · per SEC filings
Form D private placements$25.2M disclosed across 6 rounds · 2020–2026
▶$1.5MraisedJun 2026 · 19 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJun 2026 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- WINFRED PARNELLDirector
- JEFFREY COHENDirector
- ELLEN BEAUSANGDirector
- CYNTHIA HUNDORFEANDirector
- JOHN STRAHLEYExecutive Officer
- JOHN FRASERExecutive Officer, Director
- Jane PINE WOODDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedSep 2025 · 19 investors · BiotechnologyRule 506(b)
▶$3MraisedSep 2025 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ELLEN BEAUSANGDirector
- MICHAEL BUHLEExecutive Officer
- Jane PINE WOODDirector
- JACK FRASERDirector
- BRIAN HUNGERFORDExecutive Officer
- CYNTHIA HUNDORFEANDirector
- JEFFREY COHENDirector
- WINFRED PARNELLDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedMar 2025 · 27 investors · BiotechnologyRule 506(b)
▶$1.4MraisedMar 2025 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ELLEN BEAUSANGDirector
- WINFRED PARNELLDirector
- MICHAEL BUHLEExecutive Officer
- JOHN RAGARDDirector
- JANNIE HERCHUKDirector
- CELESTE FRALICKDirector
- JAMES CRAWFORDExecutive Officer
- ELLEN O'CONNOR-VOSDirector
- STEFANIE CAVANAUGHDirector
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedJul 2024 · 21 investors · BiotechnologyRule 506(b)
▶$1.9MraisedJul 2024 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Winfred ParnellDirector
- Stefanie CavanaughDirector
- Celeste FralickDirector
- Sandra MilliganExecutive Officer
- Ellen O'Connor VosDirector
- Nicole SandfordExecutive Officer, Director
- Jannie HerchukDirector
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.5MraisedFeb 2024 · 7 investors · BiotechnologyRule 506(b)
▶$6.5MraisedFeb 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Minh MerchantExecutive Officer
- Lynn O'Connor VosDirector
- Nicole SandfordExecutive Officer, Director
- Stefanie CavanaughDirector
- Winfred ParnellDirector
- Jannie HerchukDirector
- Celeste FralickDirector
- Torsten HombeckExecutive Officer
- Jody BerryExecutive Officer
- Offering amount
- $6.5M
- Amount sold
- $6.5M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedJul 2020 · 8 investors · Other Health CareRule 506(b)
▶$11MraisedJul 2020 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Veronica G. H. JordanDirector
- James T. LaFranceDirector
- James S. BurnsDirector
- Robert BeecheyExecutive Officer
- David R. SchreiberDirector
- Nancy G. CocozzaDirector
- Valerie B. PalmieriExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $11M
- Minimum investment
- $150K
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapLabcorp24 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Quest Diagnostics20 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Cancerresearchuk17 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
American Cancer Society (ACS)16 shared keywordsThe American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.
MD Anderson Cancer Center14 shared keywordsUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Companies competing with Aspira Women's Health for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- How much funding has Aspira Women's Health raised?
- Aspira Women's Health has disclosed $25.2M raised across 6 rounds.
- Where is Aspira Women's Health headquartered?
- Aspira Women's Health is headquartered in Austin, US.

